The potential of patients' peripheral blood mononuclear cells to differentiate into dendritic cells after hematopoietic stem cell transplantation.

[1]  R. Storb,et al.  Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  Kenji Takahashi,et al.  Effects of proteoglycan extracted from nasal cartilage of salmon heads on maturation of dendritic cells derived from human peripheral blood monocytes. , 2010, Biological & pharmaceutical bulletin.

[3]  K. Akashi,et al.  Plasmacytoid dendritic cells prime alloreactive T cells to mediate graft-versus-host disease as antigen-presenting cells. , 2009, Blood.

[4]  M. Beyer,et al.  Activation of autologous leukemia‐specific T cells in acute myeloid leukemia: monocyte‐derived dendritic cells cocultured with leukemic blasts compared with leukemia‐derived dendritic cells , 2008, European journal of haematology.

[5]  Kenji Takahashi,et al.  Differential induction from X-irradiated human peripheral blood monocytes to dendritic cells. , 2008, Journal of radiation research.

[6]  W. Shlomchik,et al.  Graft-versus-host disease , 2007, Nature Reviews Immunology.

[7]  J. Lau,et al.  Activated Circulating Dendritic Cells After Hematopoietic Stem Cell Transplantation Predict Acute Graft-Versus-Host Disease , 2007, Transplantation.

[8]  M. Remberger,et al.  Increased gene expression of chemokine receptors is correlated with acute graft-versus-host disease after allogeneic stem cell transplantation. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  S. Adams,et al.  Manipulating dendritic cell biology for the active immunotherapy of cancer. , 2004, Blood.

[10]  D. Jain,et al.  Donor APCs are required for maximal GVHD but not for GVL , 2004, Nature Medicine.

[11]  U. Duffner,et al.  Host Dendritic Cells Alone Are Sufficient to Initiate Acute Graft-versus-Host Disease1 , 2004, The Journal of Immunology.

[12]  Katsuaki Sato,et al.  Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. , 2003, Immunity.

[13]  R. Fanin,et al.  Dendritic cell recovery after autologous stem cell transplantation , 2002, Bone Marrow Transplantation.

[14]  D. Rubinstein,et al.  Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. , 1998, Blood.

[15]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[16]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[17]  T. Kalina,et al.  Kinetics of dendritic cells reconstitution and costimulatory molecules expression after myeloablative allogeneic haematopoetic stem cell transplantation: implications for the development of acute graft-versus host disease. , 2009, Clinical immunology.

[18]  D. Duda,et al.  CCR5 deletion mutation and its association with the risk of developing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. , 2006, Haematologica.

[19]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.